» Articles » PMID: 33279630

Lesions in the Lungs of Fatal Corona Virus Disease Covid-19

Overview
Journal Ann Anat
Date 2020 Dec 6
PMID 33279630
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The corona virus outbreak in Wuhan, China, at the end of 2019 has rapidly evolved into a pandemic which is still virulent in many countries. An infection with SARS-CoV-2 can lead to corona virus disease (Covid-19). This paper presents an overview of the knowledge gained so far with regard to histopathological lung lesions in fatal courses of Covid-19. The main findings were diffuse alveolar damage and micro-angiopathies. These included the development of hyaline membranes, thrombi, endothelial inflammation, haemorrhages and angiogenesis. Overall, the vessel lesions seemed to be more lethal than the diffuse alveolar damage. There was obvious hyperreactivity and hyperinflammation of the cellular immune system. An expanded T-cell memory may explain the increased risk of a severe course in the elderly.

Citing Articles

COVID-19 Coagulopathy.

Rettew A, Garrahy I, Rahimian S, Brown R, Sangha N Life (Basel). 2024; 14(8).

PMID: 39202695 PMC: 11355811. DOI: 10.3390/life14080953.


Pulmonary Function, Computed Tomography Lung Abnormalities, and Small Airway Disease after COVID-19: 3-, 6-, and 9-Month Follow-Up.

Klos K, Jaskola-Polkowska D, Plewka-Barcik K, Rozynska R, Pietruszka-Waleka E, Zabicka M J Clin Med. 2024; 13(10).

PMID: 38792275 PMC: 11122501. DOI: 10.3390/jcm13102733.


Analysis of Leukocyte Subpopulations by Flow Cytometry during Hospitalization Depending on the Severity of COVID-19 Course.

Rutkowska E, Kwiecien I, Pietruszka-Waleka E, Wiesik-Szewczyk E, Rzepecki P, Jahnz-Rozyk K Biomedicines. 2023; 11(10).

PMID: 37893102 PMC: 10604221. DOI: 10.3390/biomedicines11102728.


Clinical and Genetic Characteristics of Coronaviruses with Particular Emphasis on SARS-CoV-2 Virus.

Iwanicka J, Iwanicki T, Kaczmarczyk M, Mazur W Pol J Microbiol. 2022; 71(2):141-159.

PMID: 35716167 PMC: 9252140. DOI: 10.33073/pjm-2022-022.


Vasculopathy in COVID-19.

Flaumenhaft R, Enjyoji K, Schmaier A Blood. 2022; 140(3):222-235.

PMID: 34986238 PMC: 8736280. DOI: 10.1182/blood.2021012250.


References
1.
Ren X, Glende J, Al-Falah M, de Vries V, Schwegmann-Wessels C, Qu X . Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus. J Gen Virol. 2006; 87(Pt 6):1691-1695. DOI: 10.1099/vir.0.81749-0. View

2.
Pabst R, Tschernig T . Periarterial leukocyte accumulation in allergic airway inflammation. Am J Respir Crit Care Med. 2006; 174(7):840. DOI: 10.1164/ajrccm.174.7.840. View

3.
Schmiedl A, Kerber-Momot T, Munder A, Pabst R, Tschernig T . Bacterial distribution in lung parenchyma early after pulmonary infection with Pseudomonas aeruginosa. Cell Tissue Res. 2010; 342(1):67-73. DOI: 10.1007/s00441-010-1036-y. View

4.
Ackermann M, Verleden S, Kuehnel M, Haverich A, Welte T, Laenger F . Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med. 2020; 383(2):120-128. PMC: 7412750. DOI: 10.1056/NEJMoa2015432. View

5.
Thieme C, Anft M, Paniskaki K, Blazquez-Navarro A, Doevelaar A, Seibert F . Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients. Cell Rep Med. 2020; 1(6):100092. PMC: 7456276. DOI: 10.1016/j.xcrm.2020.100092. View